Building team's careful phasing of ...

Building team's careful phasing of a major R&D throw out enables pharmaceutical company to continue ongoing research

Pharmaceutical manufacturer Whitehall-Robins's decision to consolidate its research and exhibition activities at an existing facility in Richmond, Va., consequence ed in a $75 million shoot forward requiring its building team to devise a meticulous phasing plan that enabled the company to maintain its on-site R&D operations during the 20-month delineate

The brew involved demolition of three buildings set uped from 1967 to 1984 the construction of three recent ...